Clinigene International Ltd   Report issue

Contributed to NME For profit Phase 2
Founded: Bengaluru India (2000)

Organization Overview

First Clinical Trial
2010
NCT00926068
First Marketed Drug
2000
foscarnet (foscavir)
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Clinigen Healthcare Ltd | CLINIGEN HLTHCARE

Active Ingredients

Marketed Drugs (3)

amifostine (ethyol) (1995)

dexrazoxane (zinecard) (2007)

foscarnet (foscavir) (1991 NDA)

Drugs in Phase 2 Trials (1)

ho/03/03 (1 trial)

Drugs in Other Trials (2)

palopegteriparatide (1 trial)

tafasitamab (Monjuvi) (1 trial)

Indications

Approved Indications


 

Cytomegalovirus Retinitis

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3